Ten‐year patterns in blood product utilization during cardiothoracic surgery with cardiopulmonary bypass in a tertiary hospital

Abstract

This institutional report shows a large reduction in blood loss and transfusion requirements in cardiac surgery over a 10-year period. This reduction is most probably attributed to structural cell salvage, reduced intraoperative fluid volumes, and the increase in the lowest intraoperative body temperature.

Lung Transplant With Cardiopulmonary Bypass: Impact of Blood Transfusion on Rejection, Function, and Late Mortality

“…Second, time effect is a likely confounding variable for survival analyses within this decade-long study, as lung transplant survival has dramatically improved over the last decade [1]. Over time, our approach to and behavior regarding blood product usage may have become more restrictive and less liberal [20]. Time effect as a potential confounder was adjusted by including the year of transplantation in our regression model.…”

Established and potential predictors of blood loss during lung transplant surgery

“…Intraoperative body temperature had no impact on red blood cell requirements (22). These findings might be of particular interest for the numerous patients undergoing lung transplantation on CPB.…”

“…In a retrospective study in cardiothoracic surgery on cardiopulmonary bypass (CPB), increased BMI, and preoperative hemoglobin levels were associated with reduced use of PRBC, whereas a higher EuroSCORE (European System for Cardiac Operative Risk Evaluation), longer CPB duration, and a higher fluid balance at 6 hours after surgery were correlated to an increased use of red blood cells (22). Intraoperative body temperature had no impact on red blood cell requirements (22).…”

Patient-oriented blood-saving concept in operations with cardiopulmonary bypass

“…В целом от-мечается «неправильный» (отличный от истинного) рас-чет Ht у 18-21% пациентов, подвергающихся вмешатель-ствам в условиях ИК [23]. Другие методы снижения уров-ня гемодилюции многими авторами считаются достаточ-ными: коррекция анемии до операции [24]; использова-ние тренд-положения, вазопрессоров и коллоидов на вводном наркозе [25]; хирургические методы снижения кровопотери, включая реинфузию сепарированных эри-троцитов; минимизация объема контура ИК или (по огра-ниченным показаниям) использование MiECC-систем [26,27]; применение кровяной кардиоплегии [28], пре-вентивное использование донорских эритроцитов только при реоперациях [29].…”